MassChallenge Switzerland, part of MassChallenge’s global network for innovators and zero-equity startup accelerators, yesterday hosted its 10th Anniversary Awards Ceremony in Lausanne, Switzerland.

Diabetes leads to nerve damage in half of all people affected, starting in the feet. The smart sock from ETH spin-off MYNERVA helps sufferers feel the ground again when walking and alleviates their chronic pain.

MYNERVA AG got first place in the “Health & Nutrition” vertical and awarded with the Grand Prize worth CHF 150K.

MYNERVA and Apersys, current and alumni Wyss Zurich startups, joining the top 8% of over 1,500 global applicants selected for the world-class accelerator MassChallange.

Let’s talk about well-being for a better diabetes life.

Our current project, MYNERVA, was awarded the Expert Jury Award for most investable company, as well as the Audience Award.

Our current project MYNERVA, has been shortlisted as a finalist for the Swiss Technology Award (Inventors category). The Swiss Technology Award is the leading technology prize in Switzerland.

project MYNERVA and Apersys AG were recently selected to join the Venture Leaders Medtech 2024. They will travel with 8 other leaders to Boston from 4 to 6 November 2024.

(Image credit: Startupticker.ch) Three Wyss Zurich projects, MYNERVA, Tandem and Tethys, have made it to the Top 15 selection of this year’s De Vigier Award.